title: [Is our approach to thyroid nodules and differentiated thyroid carcinoma in agreement with the American guideline and European consensus?].
abstract: BACKGROUND
  The aim of this study was to assess the approaches of specialists in Spain to patients with thyroid nodules and differentiated thyroid carcinoma and to compare them with the American guideline and European consensus.
  
  
  METHODS
  We performed a cross-sectional study based on a questionnaire addressed to clinical endocrinologists specialized in thyroid cancer and specialists in nuclear medicine throughout Spain.
  
  
  RESULTS
  A total of 177 questionnaires were completed, representing an overall response rate of 85%; 74% of responses were from endocrinologists and 24% from physicians active in nuclear medicine; 82% of respondents worked in third-level hospitals, 10% in second level hospitals and the remainder in private practice. Most used ultrasonography and cytology to assess thyroid nodules and collaborated with a group of surgeons expert in thyroid surgery. The majority preferred total or subtotal thyroidectomy in tumors with a diameter of 1 cm or more, and systematic lymph node dissection. Only 43 (24%) preferred prophylactic central lymph node dissection. Eighty-one respondents (45%) would still use whole body scan with ¹³¹I or ¹²³I before ¹³¹I ablation. Follow-up was based on cervical echography and thyroglobulin determination; however, 101 (57%) respondents continued to use diagnostic whole body scan in the follow-up.
  
  
  CONCLUSIONS
  The approaches of the respondents were mainly in accordance with the guideline and consensus, although some variations were found, especially in the use of whole body scan with ¹³¹I before ablation and in follow-up.
authors.affiliation: Hospital de Bellvitge, Departmento de Endocrinología, Barcelona, España. jmgs@bellvitgehospital.cat
authors.forename: José Manuel
authors.initials: JM
authors.lastname: Gómez Sáez
mesh_terms: D002277:Carcinoma / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D003245:Consensus Statements as Topic; D003430:Cross-Sectional Studies; D003625:Data Collection; D004363:Drug Utilization; D004704:Endocrinology; D005060:Europe; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008197:Lymph Node Excision / Q000706:statistics & numerical data; D009367:Neoplasm Staging / Q000379:methods / Q000706:statistics & numerical data; D009683:Nuclear Medicine; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011877:Radionuclide Imaging / Q000706:statistics & numerical data; D013030:Spain; D013954:Thyroglobulin / Q000097:blood; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D016606:Thyroid Nodule / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D013965:Thyroidectomy / Q000706:statistics & numerical data; D013974:Thyroxine / Q000627:therapeutic use; D014463:Ultrasonography / Q000706:statistics & numerical data; D014481:United States; D051598:Whole Body Imaging / Q000706:statistics & numerical data
chemical_list: D007457:Iodine Radioisotopes; D013954:Thyroglobulin; D013974:Thyroxine